Application Nr Approved Date Route Status External Links
ANDA079057 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Alfuzosin Hydrochloride Extended-Release Tablets Are Indicated For The Treatment Of Signs And Symptoms Of Benign Prostatic Hyperplasia. Alfuzosin Hydrochloride Is An Alpha Adrenergic Antagonist, Indicated For The Treatment Of Signs And Symptoms Of Benign Prostatic Hyperplasia. ( 1 ) Important Limitations Of Use: Alfuzosin Hydrochloride Extended-Release Tablets Are Not Indicated For Treatment Of Hypertension. ( 1.1 ) Alfuzosin Hydrochloride Extended-Release Tablets Are Not Indicated For Use In The Pediatric Population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations Of Use Alfuzosin Hydrochloride Extended-Release Tabletsare Not Indicated For The Treatment Of Hypertension. Alfuzosin Hydrochloride Extended-Release Tablets Are Not Indicated For Use In The Pediatric Population.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alfuzosin Hydrochloride ALFUZOSIN HYDROCHLORIDE ZINC1542392

Comments